NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE
NAD is a Ligand Of Interest in 5AXA designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 5AXA_NAD_A_501 | 92% | 25% | 0.071 | 0.968 | 1.51 | 1.45 | 5 | 7 | 1 | 0 | 100% | 1 |
| 5AXA_NAD_C_501 | 89% | 27% | 0.073 | 0.959 | 1.56 | 1.28 | 4 | 6 | 1 | 0 | 100% | 1 |
| 5AXB_NAD_C_501 | 98% | 25% | 0.054 | 0.985 | 1.51 | 1.47 | 4 | 6 | 0 | 0 | 100% | 1 |
| 5AXD_NAD_C_501 | 97% | 26% | 0.06 | 0.981 | 1.48 | 1.43 | 3 | 7 | 1 | 0 | 100% | 1 |
| 5AXC_NAD_A_501 | 95% | 20% | 0.06 | 0.973 | 1.5 | 1.79 | 3 | 10 | 0 | 0 | 100% | 1 |
| 5W4B_NAD_D_501 | 90% | 43% | 0.091 | 0.982 | 0.83 | 1.27 | 2 | 5 | 0 | 0 | 100% | 1 |
| 5W49_NAD_A_501 | 90% | 44% | 0.09 | 0.978 | 0.97 | 1.09 | 2 | 4 | 0 | 0 | 100% | 1 |
| 3CMC_NAD_R_408 | 100% | 19% | 0.016 | 0.998 | 1.63 | 1.74 | 4 | 9 | 0 | 0 | 100% | 1 |
| 4RQU_NAD_B_403 | 100% | 3% | 0.019 | 0.997 | 3.51 | 2.61 | 13 | 18 | 0 | 0 | 100% | 1 |
| 2O2Y_NAD_D_550 | 100% | 17% | 0.023 | 0.996 | 1.65 | 1.87 | 4 | 9 | 0 | 0 | 100% | 1 |
| 2BJK_NAD_A_1517 | 100% | 55% | 0.025 | 0.995 | 0.72 | 0.86 | - | 1 | 1 | 0 | 100% | 0.86 |
| 3EC7_NAD_A_400 | 100% | 17% | 0.025 | 0.995 | 1.8 | 1.74 | 5 | 8 | 1 | 0 | 100% | 1 |
